scholarly article | Q13442814 |
P356 | DOI | 10.3171/JNS.2007.106.4.646 |
P698 | PubMed publication ID | 17432717 |
P50 | author | Gordon M. Keller | Q17399248 |
Isabelle M. Germano | Q18150710 | ||
P2093 | author name string | Mahmud Uzzaman | |
P433 | issue | 4 | |
P921 | main subject | temozolomide | Q425088 |
P304 | page(s) | 646-651 | |
P577 | publication date | 2007-04-01 | |
P1433 | published in | Journal of Neurosurgery | Q15708886 |
P1476 | title | Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells | |
P478 | volume | 106 |
Q39167592 | Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment |
Q28543237 | Characterization of a novel anti-cancer compound for astrocytomas |
Q36994063 | Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits. |
Q39614785 | HFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A. |
Q26772309 | Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications |
Q34803686 | In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas |
Q37236243 | Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas. |
Q39538477 | Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells. |
Q55445418 | Natural products: a hope for glioblastoma patients. |
Q37585453 | Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma |
Q36687919 | Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line |
Q37403279 | Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity |
Q39359487 | Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway |
Q37818222 | Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma |
Q38235856 | Stem cells and gliomas: past, present, and future. |
Q34240433 | Stem cells as therapeutic vehicles for the treatment of high-grade gliomas |
Q38941438 | Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma |
Q37356520 | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide |
Q91792247 | Temozolomide resistance in glioblastoma multiforme |
Q42479312 | Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein |
Q35674453 | The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells |
Q36527593 | The art of gene therapy for glioma: a review of the challenging road to the bedside |
Search more.